SCHEMBL26753979

SCHEMBL26753979

CNC(=O)[C@@H]1CCC(n2cnc3c(NC)nc(-c4cccnc4)nc32)O1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CHKA P35790 1/20 0.43
▸ ADORA3 P0DMS8 13/20 0.43
▸ ADORA1 P30542 6/20 0.43
▸ ADORA2A P29274 4/20 0.43
▸ ADORA2B P29275 1/20 0.41
▸ CD99 P14209 1/20 0.40
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ YTHDC1 Q96MU7 1/20 0.38
▸ P2RY1 P47900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24600854 0.84 ADORA3 (0.61) CHKAADORA3ADORA1ADORA2AADORA2B
SCHEMBL29073477 0.81 ADORA3 (0.65) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL26628399 0.81 ADORA3 (0.65) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL29762311 0.81 ADORA3 (0.65) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL29073483 0.81 ADORA3 (0.65) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL24601002 0.77 ADORA3 (0.47) ADORA3ADORA1ADORA2AADORA2BCYP1A2
SCHEMBL30634876 0.76 CYP1A2 (0.39) CHKAADORA3ADORA1ADORA2ACYP1A2
SCHEMBL29073847 0.75 ADORA3 (0.62) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL24601367 0.75 ADORA3 (0.62) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL29073850 0.75 ADORA3 (0.62) ADORA3ADORA1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273153-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF Zhejiang Vimgreen Pharmaceuticals, Ltd (CN) 2023-11-08 — — EP disclosed
Send feedback